Asthma, COPD, smoking cessation Flashcards
Drugs that can cause PAH
cocaine
SSRI use during pregnancy (increase the risk of persistent PPHN)
weight loss drugs
methamphetamines/amphetamines
diagnosis
right heart catheterization is required to confirm PAH
Responder
-if MAP falls by at least 10 mmHg
-initially treated with CCB such as nifedipine, diltiazem, and amlodipine
non-responder
-prostacyclin analogs and receptor agonists
-endothelin receptor antagonists
-PDE-5 inhibitors
-soluble guanylate cyclase (sGC) stimulator
Prostacyclin analogs and receptor agonists
epoprostenol (Flolan, Velteri)
-continuous IV infusion
-vasodilation reactions (hypotension, flushing)
-risk of sepsis and blood stream infections from chronic infusions
-potent vasodilator; avoid interruption and sudden large dose reductions
-protect from light
Endothelian receptor antagonists
-bosenten, ambrisentan
-REMS: teratogenic and must have a negative pregnancy test before initiation and monthly thereafter
-hepatotoxicity with bosentan
PDE-5 inhibitors (PAH)
-Sildenafil (Revatio), Tadalafil (Adcirca)
-contraindication: use with nitrates and riociguat
-hearing loss, vision loss, hypotension, priapism
soluble guanylate cyclase stimulator
-riociguat (adempas)
-REMS: teratogenic and must have a negative pregnancy test before initiation and monthly thereafter
-contraindications: use with PDE-5 inhibitors
-hypotension
drugs that can cause pulmonary fibrosis
amiodarone/dronedarone
bleomycin
busulfan
carmustine
lomustine
FEV1
how much air can be forcefully exhaled in one second
FVC
after taking a deep breath, the maximum volume of air that is exhaled
FEV1/FVC
the percentage of air capacity that can be forcefully echaled in one second
asthma relievers
low-dose ICS + formoterol
inhaled SABA
systemic steroids
inhaled epi
inhaled SAMA
asthma controllers
ICS (first line for all patients)
LABAs (only to be used in combo)
oral leukotriene receptor antagonists (LTRAs)
theophylline (serum conc monitoring)
LAMAs
mAbs
Asthma: step 1: symptoms < 2x/month
PRN ICS + formoterol or SABA + low dose ICS
Asthma: step 2: symptoms or need for SABA > 2x/month
Rescue: PRN ICS + formoterol OR SABA w/ controller
Controller: low dose ICS
Asthma: step 3: symptoms on most days or waking at night > 1x/week
1: low dose ICS-formoterol (as rescue and controller)
2. SABA + low-dose ICS-LABA
Asthma: step 4: symptoms daily, waking at night > 1x a week, or initial presentation is with an exacerbation
- low dose ICS-formoterol + medium dose ICS-formoterol
- SABA + medium dose ICS-LABA`
Asthma: step 5
- low dose ICS-formoterol + high-dose ICS-formoterol
- SABA + high dose ICS-LABA
Asthma: SABA
albuterol (ProAir HFA)
-MDI/DPI
-nebs
-PO
-nervousness, tremor, tachycardia, palpitations, cough, hyperglycemia, decrease K
Asthma: ICS Inhalers
Salmeterol (serevent diskus), beclomethasone (QVAR Redihaler)
Budesonie (Pulmicort)
Budesonide + formoterol (symbicort)
Fluticasone (Flovent HFA/Diskus, Annuity)
Fluticasone + salmoterol (Advair Diskus)
Fluticasone + vilanterol (Breo Ellipta)
Mometasone + formoterol (Dulera)
Asthma: ICS
-increased risk of asthma-related events
-increased risk of hospitalizations in pediatric and adolescent patients
-dysphonia, oral candidiasis, cough
-rinse mouth
Controller inhalers: ICS
Asthma: Beclomethasone, Budesonide, Fluticasone
COPD: no single agent is FDA approved
Controller inhalers: LABA
Asthma and COPD: Salmeterol (Serevent Diskus)